These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 15041366)
1. Experience with cyclosporine in living-donor lobar lung transplantation. Date H Transplant Proc; 2004 Mar; 36(2 Suppl):349S-351S. PubMed ID: 15041366 [TBL] [Abstract][Full Text] [Related]
2. Improved survival after living-donor lobar lung transplantation. Date H; Aoe M; Sano Y; Nagahiro I; Miyaji K; Goto K; Kawada M; Sano S; Shimizu N J Thorac Cardiovasc Surg; 2004 Dec; 128(6):933-40. PubMed ID: 15573079 [TBL] [Abstract][Full Text] [Related]
3. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection. Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212 [TBL] [Abstract][Full Text] [Related]
4. Tacrolimus therapy for persistent or recurrent acute rejection after lung transplantation. Horning NR; Lynch JP; Sundaresan SR; Patterson GA; Trulock EP J Heart Lung Transplant; 1998 Aug; 17(8):761-7. PubMed ID: 9730424 [TBL] [Abstract][Full Text] [Related]
5. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation. Tanaka K; Lake J; Villamil F; Levy G; Marotta P; Mies S; de Hemptinne B; Moench C Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691 [TBL] [Abstract][Full Text] [Related]
6. Living donor lobar lung transplantation: the pediatric experience. Woo MS; MacLaughlin EF; Horn MV; Wong PC; Rowland JM; Barr ML; Starnes VA Pediatr Transplant; 1998 Aug; 2(3):185-90. PubMed ID: 10084740 [TBL] [Abstract][Full Text] [Related]
7. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience. Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007 [TBL] [Abstract][Full Text] [Related]
8. Use of cyclosporine in lung transplantation. Parekh K; Trulock E; Patterson GA Transplant Proc; 2004 Mar; 36(2 Suppl):318S-322S. PubMed ID: 15041361 [TBL] [Abstract][Full Text] [Related]
9. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction]. Mota A Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737 [TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience. Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M; Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208 [TBL] [Abstract][Full Text] [Related]
13. Living-donor lobar lung transplantation for pulmonary complications after hematopoietic stem cell transplantation. Yamane M; Sano Y; Toyooka S; Okazaki M; Date H; Oto T Transplantation; 2008 Dec; 86(12):1767-70. PubMed ID: 19104419 [TBL] [Abstract][Full Text] [Related]
14. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [TBL] [Abstract][Full Text] [Related]
15. Late acute cardiac allograft rejection: new therapeutic options? Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161 [TBL] [Abstract][Full Text] [Related]
16. Living lobar lung transplantation. Bowdish ME; Barr ML Respir Care Clin N Am; 2004 Dec; 10(4):563-79. PubMed ID: 15585183 [TBL] [Abstract][Full Text] [Related]
17. Everolimus with reduced-dose cyclosporine in de novo renal transplant recipients: Philippine experience. Li JT; Danguilan RA; Cabanayan-Casasola CB; Talusan-Tomacruz Y; Ona ET Transplant Proc; 2008 Sep; 40(7):2211-3. PubMed ID: 18790195 [TBL] [Abstract][Full Text] [Related]
18. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients. Câmara NO; Dias MF; Pacheco-Silva A Clin Transplant; 2004 Aug; 18(4):450-5. PubMed ID: 15233825 [TBL] [Abstract][Full Text] [Related]
19. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation. Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762 [TBL] [Abstract][Full Text] [Related]
20. Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis. Fan Y; Xiao YB; Weng YG Transplant Proc; 2009 Jun; 41(5):1821-4. PubMed ID: 19545736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]